ECVT
Ecovyst Inc.
ECVT's fundamentals are mixed, but it looks expensive: trading at 34x earnings, about twice its usual 18x. Analysts expect strong earnings growth.
ECVT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Under pressure | |
| Stable |
ECVT's revenue and profitability are currently healthy, and its balance sheet is stable, but its cash flow is under pressure.
ECVT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $10.75 | — |
| Cheap | 16x | $5.16 | -52% |
| Fair | 18x | $5.84 | -46% |
| Expensive | 26x | $8.19 | -24% |
| Current | 34x | $10.75 | — |
Historical ranges are pointers, not guarantees.
ECVT's PE is in its expensive range at 34x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its cheap range.
ECVT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for ECVT, with profitability holding steady.
ECVT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.75 | +136% |
| Q3 2026 | $0.32 | +$1.25 |
| Q2 2026 | -$0.53 | -$0.41 |
| Q1 2026 | -$0.55 | -$0.45 |
| Q4 2025 | -$0.62 | -$0.56 |
| Q3 2025 | -$0.93 | -307% |
| Q2 2025 | -$0.12 | -126% |
| Q1 2025 | -$0.10 | -116% |
| Q4 2024 | -$0.06 | -110% |
ECVT has returned to profit: it earned $0.32 per share over the past year, after losing money the year before.
ECVT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $308.6M | +51% |
| Q2 2026 | $250M | +25% |
| Q1 2026 | $215M | +33% |
| Q4 2025 | $199.4M | +9.6% |
| Q3 2025 | $204.9M | +14% |
| Q2 2025 | $200.1M | +9.5% |
| Q1 2025 | $162.2M | +1% |
| Q4 2024 | $182M | +5.3% |
ECVT's revenue has grown year over year for nine quarters in a row: $309M last quarter, up 51% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.5% | -4.3 points |
| Q2 2026 | 7.8% | -1.2 points |
| Q1 2026 | 5.8% | +6.4 points |
| Q4 2025 | 11% | -2.7 points |
| Q3 2025 | 14% | -3.8 points |
| Q2 2025 | 8.9% | -6.3 points |
| Q1 2025 | -0.6% | -9.3 points |
| Q4 2024 | 14% | +0.4 points |
ECVT's operating margin was 9.5% last quarter, down 4.3 points from the same quarter a year ago.
ECVT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.6M | -105% |
| Q2 2026 | $3.7M | -53% |
| Q1 2026 | $2.8M | +$16.8M |
| Q4 2025 | $22.9M | -13% |
| Q3 2025 | $53.2M | +19% |
| Q2 2025 | $7.8M | +$17.1M |
| Q1 2025 | -$14M | -173% |
| Q4 2024 | $26.3M | -50% |
ECVT usually generates cash, though not every quarter: the latest was −$3M, but it generated $27M over the past year.
ECVT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -210K shares |
| 1 year | -3.7% | -4.2M shares |
| 3 years | -5.7% | -6.7M shares |
| 5 years | -19% | -26.7M shares |
| Available history | -19% | -25.5M shares |
ECVT has 111M diluted shares, down 3.7% from a year ago, with $58M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.4M |
| Q2 2026 | — |
| Q1 2026 | $36.3M |
| Q4 2025 | $19.5M |
| Q3 2025 | $5.5M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $5M |
ECVT spent $58M buying back its own shares over the past year.
ECVT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.6x | Moderate |
| Q2 2026 | 2.7x | Moderate |
| Q1 2026 | 1.5x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 5.1x | High |
| Q2 2025 | 4.7x | High |
| Q1 2025 | 4.2x | High |
| Q4 2024 | 3.8x | Elevated |
ECVT's net debt is about 2.6 years of its operating earnings (EBITDA), down from 5.1 years a year ago.
ECVT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.4 | Neutral |
| Stochastic | 43.6 | Neutral |
ECVT's weekly RSI is 48 (neutral) and its Stochastic is 44 (neutral).
ECVT PE vs Basic Materials Sector
| Metric | ECVT | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 19x | 80% above |
| PE % | 90 | 40 | 50 pts above |
ECVT is trading at 34x earnings, a 80% premium to the Basic Materials sector's median of 19x.
ECVT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.2 | 5.2% above |
| 20 week MA | $10.7 | 0.1% above |
| 50 week MA | $11.5 | 6.3% below |
| 100 week MA | $9.67 | 11% above |
| 200 week MA | $9.58 | 12% above |
ECVT's trend is mixed: it's above four of its five weekly moving averages, and 12% above its 200-week average.
ECVT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.0 | $14.0 | -18% |
| 2021 | $14.0 | $10.2 | -27% |
| 2022 | $10.2 | $8.89 | -13% |
| 2023 | $8.89 | $9.77 | +9.9% |
| 2024 | $9.77 | $7.52 | -23% |
| 2025 | $7.52 | $9.96 | +32% |
| 2026 YTD | $9.96 | $10.8 | +7.9% |
ECVT has finished lower in four of the last six years. It's up 7.9% so far in 2026.